929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

heparinoids 0.3% cream, 5 g

heparinoids 0.833% ointment, 14 g

heparinoids 0.833% ointment, 40 g

heparinoids 0.833% ointment, 5 g

hepatitis A adult vaccine 1440 ELISA units/mL injection, 1 mL syringe

hepatitis A adult vaccine 1440 ELISA units/mL injection, 1 mL vial

hepatitis A adult vaccine 1440 ELISA units/mL injection, 10 x 1 mL vials

hepatitis A vaccine injection [0.5 mL chamber] (&) typhoid inactivated vaccine injection [0.5 mL chamber], 1 mL dual chamber syringe

hepatitis A child/adult vaccine injection, 0.5 mL syringe

hepatitis A child/adolescent vaccine 25 units/0.5 mL injection, 0.5 mL syringe

hepatitis A child/adolescent vaccine 25 units/0.5 mL injection, 0.5 mL vial

hepatitis A + hepatitis B child vaccine injection, 0.5 mL syringe

hepatitis A + hepatitis B child vaccine injection, 0.5 mL vial

hepatitis A adult vaccine 50 units/mL injection, 1 mL syringe

hepatitis A adult vaccine 50 units/mL injection, 1 mL vial

hepatitis A + hepatitis B adult vaccine injection, 1 mL syringe

hepatitis A + hepatitis B adult vaccine injection, 1 mL vial

hepatitis A + hepatitis B adult vaccine injection, 10 x 1 mL syringes

hepatitis A + hepatitis B adult vaccine injection, 10 x 1 mL vials

hepatitis A child/adolescent vaccine 720 ELISA units/0.5 mL injection, 0.5 mL syringe

hepatitis A child/adolescent vaccine 720 ELISA units/0.5 mL injection, 0.5 mL vial

hepatitis A child/adolescent vaccine 720 ELISA units/0.5 mL injection, 10 x 0.5 mL vials

hepatitis B child vaccine 10 microgram/0.5 mL injection, 0.5 mL syringe

hepatitis B child vaccine 10 microgram/0.5 mL injection, 0.5 mL vial

hepatitis B child vaccine 10 microgram/0.5 mL injection, 10 x 0.5 mL syringes

hepatitis B child vaccine 10 microgram/0.5 mL injection, 10 x 0.5 mL vials

hepatitis B child vaccine 10 microgram/0.5 mL injection, 25 x 0.5 mL vials

hepatitis B adult vaccine 10 microgram/mL injection, 1 mL syringe

hepatitis B adult vaccine 10 microgram/mL injection, 1 mL vial

hepatitis B adult vaccine 10 microgram/mL injection, 10 x 1 mL syringes

hepatitis B adult vaccine 10 microgram/mL injection, 10 x 1 mL vials

hepatitis B adult vaccine 20 microgram/mL injection, 1 mL syringe

hepatitis B adult vaccine 20 microgram/mL injection, 1 mL vial

hepatitis B adult vaccine 20 microgram/mL injection, 10 x 1 mL syringes

hepatitis B adult vaccine 20 microgram/mL injection, 10 x 1 mL vials

hepatitis B adult vaccine 20 microgram/mL injection, 25 x 1 mL syringes

hepatitis B adult vaccine 20 microgram/mL injection, 25 x 1 mL vials

hepatitis B dialysis vaccine injection, 1 mL vial

hepatitis B child vaccine 5 microgram/0.5 mL injection, 0.5 mL syringe

hepatitis B child vaccine 5 microgram/0.5 mL injection, 0.5 mL vial

hepatitis B child vaccine 5 microgram/0.5 mL injection, 10 x 0.5 mL syringes

hepatitis B child vaccine 5 microgram/0.5 mL injection, 10 x 0.5 mL vials

hepatitis B virus immunoglobulin 100 units injection, 1 vial

hepatitis B virus immunoglobulin 400 units injection, 1 vial

hexachlorophene 3% lotion, 200 g

hexaminolevulinate 85 mg injection [1 vial] (&) inert substance diluent [50 mL syringe], 1 pack

hexaminolevulinate 85 mg injection [1 vial] (&) inert substance diluent [50 mL vial], 1 pack

hexylresorcinol 2.4 mg lozenge, 16

hexylresorcinol 2.4 mg lozenge, 2

hexylresorcinol 2.4 mg lozenge, 24

hexylresorcinol 2.4 mg lozenge, 32 lozenges (medicinal product pack)

hexylresorcinol 2.4 mg lozenge, 4

hexylresorcinol 2.4 mg lozenge, 8

hexylresorcinol 2.5 mg lozenge, 16

hexylresorcinol 2.5 mg lozenge, 36

psyllium husk powder 375 mg/g + high amylose maize starch 375 mg/g powder for oral liquid, 440 g

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio long chain fat to carbohydrate plus protein) powder for oral liquid, 300 g

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydate plus protein) powder for oral liquid, 300 g

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydrate plus protein) oral liquid, 32 x 200 mL cartons

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate oral semi-solid, 36 x 100 g tubs

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate oral semi-solid, 48 x 100 g tubs

high selenium yeast 83.4 mg (selenium 100 microgram) tablet, 100

homatropine hydrobromide 2% eye drops, 15 mL

homosalate 4.5% + menthyl anthranilate 4.8% + octyl methoxycinnamate 7.4% + octyl salicylate 5% + oxybenzone 5.2% stick, 4.25 g

honey bee venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial] (&) inert substance diluent [3 x 1.8 mL vials], 1 pack

honey bee venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack

human chorionic gonadotrophin 1500 units injection [3 ampoules] (&) inert substance diluent [3 x 1 mL ampoules], 1 pack

human chorionic gonadotrophin 1500 units injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack

human chorionic gonadotrophin 500 units injection [3 ampoules] (&) inert substance diluent [3 x 1 mL ampoules], 1 pack

human chorionic gonadotrophin 5000 units injection [1 ampoule] (&) inert substance diluent [1 mL ampoule], 1 pack

human chorionic gonadotrophin 5000 units injection [1 vial] (&) inert substance diluent [1 mL vial], 1 pack

human chorionic gonadotrophin 5000 units injection [3 ampoules] (&) inert substance diluent [3 x 1 mL ampoules], 1 pack

human chorionic gonadotrophin 5000 units injection [3 vials] (&) inert substance diluent [3 x 1 mL syringes], 1 pack

human chorionic gonadotrophin 5000 units injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack

human menopausal gonadotrophin 1200 units injection [1 vial] (&) inert substance diluent [2 x 1 mL syringes], 1 pack

human menopausal gonadotrophin 600 units injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack

human menopausal gonadotrophin 625 units/mL injection, 0.96 mL pen device

human menopausal gonadotrophin 625 units/mL injection, 1.92 mL pen device

human papillomavirus quadrivalent vaccine injection, 0.5 mL syringe

human papillomavirus quadrivalent vaccine injection, 0.5 mL vial

human papillomavirus quadrivalent vaccine injection, 10 x 0.5 mL syringes

human papillomavirus quadrivalent vaccine injection, 10 x 0.5 mL vials

human papillomavirus 9 valent vaccine injection, 0.5 mL syringe

human papillomavirus 9 valent vaccine injection, 0.5 mL vial

human papillomavirus 9 valent vaccine injection, 10 x 0.5 mL syringes

human papillomavirus 9 valent vaccine injection, 10 x 0.5 mL vials

human papillomavirus bivalent vaccine injection, 0.5 mL syringe

human papillomavirus bivalent vaccine injection, 0.5 mL vial

human papillomavirus bivalent vaccine injection, 10 x 0.5 mL syringes

human papillomavirus bivalent vaccine injection, 10 x 0.5 mL vials

human papillomavirus bivalent vaccine injection, 100 x 0.5 mL vials

human papillomavirus bivalent vaccine injection, 20 x 0.5 mL syringes

human thrombin 1600 international units / 2 mL solution, 1 x 2 mL vial (medicinal product pack)

human thrombin 4000 units/5 mL solution, 5 mL vial

human thrombin 800 units/mL solution, 1 mL vial

hyaluronate sodium 0.1% eye drops, 10 mL

hyaluronate sodium 0.2% eye drops, 10 mL

sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe

hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, 50 mL syringe

Start Previous Page 84 of 160 Next End

Reference Sets

Reference set descriptor